Monopar Therapeutics (MNPR) Insider Trading Disclosures
Monopar Therapeutics (MNPR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MNPR
CIK: 1645469
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BPM LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAlan Alvarez Luna
Audit LocationSanta Rosa, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0001437749-26-032048 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001437749-26-031927 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001437749-26-031925 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001437749-26-031924 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009981 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | FORM 4 | 0001437749-26-031411 | View SEC Doc Filr Page |
| 144 | 2026-09-24 | — | 144 Filing | 0001950047-26-009797 | View SEC Doc Filr Page |
| 4/A | 2026-08-28 | 2026-08-26 | FORM 4/A | 0001437749-26-029235 | View SEC Doc Filr Page |
| 4/A | 2026-08-28 | 2026-08-25 | FORM 4/A | 0001437749-26-029228 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-26 | FORM 4 | 0001437749-26-029121 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-26 | FORM 4 | 0001437749-26-029116 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | FORM 4 | 0001437749-26-029115 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001950047-26-008724 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001950047-26-008721 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001950047-26-008691 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0002060757-26-000047 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-004969 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | FORM 8-K | 0001437749-26-027165 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | FORM 10-Q | 0001437749-26-027164 | View SEC Doc Filr Page |
| S-8 POS | 2026-07-22 | — | FORM S-8 POS | 0001437749-26-024132 | View SEC Doc Filr Page |
| S-8 POS | 2026-07-22 | — | FORM S-8 POS | 0001437749-26-024131 | View SEC Doc Filr Page |
| S-8 POS | 2026-07-22 | — | FORM S-8 POS | 0001437749-26-024130 | View SEC Doc Filr Page |
| S-8 POS | 2026-07-22 | — | FORM S-8 POS | 0001437749-26-024129 | View SEC Doc Filr Page |
| S-8 | 2026-07-22 | — | FORM S-8 | 0001437749-26-024127 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-22 | FORM 8-K | 0001437749-26-024041 | View SEC Doc Filr Page |